GetTopicDetailResponse(id=306a3368084, topicName=北京科興, introduction=北京科興, content=null, image=null, comments=3, allHits=1484, url=https://h5.medsci.cn/topic?id=33680, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=98253, tagList=[TagDto(tagId=98253, tagName=北京科興)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1877777, encodeId=d32318e777773, content=<a href='/topic/show?id=306a3368084' target=_blank style='color:#2F92EE;'>#北京科興#</a>, objectTitle=北京科興生物的新冠COVID-19疫苗在巴西的III期臨床試驗被暫停, objectType=article, longId=203249, objectId=a99020324958, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a99020324958, replyNumber=0, likeNumber=108, createdTime=2021-09-28, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a99020324958, moduleTitle=北京科興生物的新冠COVID-19疫苗在巴西的III期臨床試驗被暫停, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a99020324958)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1877778, encodeId=ceb618e77781d, content=<a href='/topic/show?id=306a3368084' target=_blank style='color:#2F92EE;'>#北京科興#</a>, objectTitle=北京科興新冠滅活疫苗Ⅲ期臨床研究數(shù)據(jù)公布, objectType=article, longId=206841, objectId=0592206841c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0592206841c7, replyNumber=0, likeNumber=122, createdTime=2021-03-14, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0592206841c7, moduleTitle=北京科興新冠滅活疫苗Ⅲ期臨床研究數(shù)據(jù)公布, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0592206841c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1877776, encodeId=e1ec18e7776e0, content=<a href='/topic/show?id=306a3368084' target=_blank style='color:#2F92EE;'>#北京科興#</a>, objectTitle=北京科興旗下水痘疫苗獲得NMPA頒發(fā)的產(chǎn)品許可證, objectType=article, longId=185425, objectId=87381854259c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87381854259c, replyNumber=0, likeNumber=103, createdTime=2020-03-29, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87381854259c, moduleTitle=北京科興旗下水痘疫苗獲得NMPA頒發(fā)的產(chǎn)品許可證, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=87381854259c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
